Your session is about to expire
← Back to Search
Sildenafil administration for Patent Foramen Ovale
Phase < 1
Waitlist Available
Led By Andrew Lovering, PhD
Research Sponsored by University of Oregon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 hour post intervention
Awards & highlights
Study Summary
This trial will study Croatian breath-hold and SCUBA divers to see if there is a relationship between PFO and IPAVA blood flow and to test if a placebo-controlled intervention (sildenafil) can reduce pulmonary arterial pressure.
Eligible Conditions
- Patent Foramen Ovale
- Intrapulmonary Arteriovenous Anastomosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 hour post intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 hour post intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Q-IPAVA
Concentration Of CRP
Concentration Of MMP-2
+11 moreTrial Design
2Treatment groups
Active Control
Placebo Group
Group I: Sildenafil administrationActive Control1 Intervention
Administration of 50mg sildenafil one time, one hour prior to measurements
Group II: Placebo administrationPlacebo Group1 Intervention
Administration of 50mg placebo one time, one hour prior to measurements
Find a Location
Who is running the clinical trial?
University of OregonLead Sponsor
80 Previous Clinical Trials
46,677 Total Patients Enrolled
Andrew Lovering, PhDPrincipal InvestigatorUniversity of Oregon
1 Previous Clinical Trials
10 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger